Kyowa Kirin Co. Ltd. (KYKOF)
PNK: KYKOF
· Real-Time Price · USD
14.75
0.00 (0.00%)
At close: Apr 29, 2025, 12:47 PM
0.00% (1D)
| Bid | 13.69 |
| Market Cap | 7.72B |
| Revenue (ttm) | 476B |
| Net Income (ttm) | 97.32B |
| EPS (ttm) | 0.8 |
| PE Ratio (ttm) | 18.44 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 15.04 |
| Volume | 9 |
| Avg. Volume (20D) | 31 |
| Open | 13.58 |
| Previous Close | 14.75 |
| Day's Range | 13.58 - 14.75 |
| 52-Week Range | 12.32 - 22.21 |
| Beta | 0.18 |
About KYKOF
Kyowa Kirin Co., Ltd. manufactures and markets pharmaceuticals that focuses on the therapeutic areas of oncology, nephrology, central nervous system, and immunology worldwide. Its products include ABSTRAL, a sublingual formulation of fentanyl used for the management of episodes of breakthrough pain experienced by cancer patients; ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for h...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Aug 17, 2012
Employees 5,669
Stock Exchange PNK
Ticker Symbol KYKOF
Website https://www.kyowakirin.com
